Tucson, Ariz. – Researchers in the University of Arizona College of Medicine – Tucson have invented a new class of non-opioid compounds to treat pain. Animal testing has shown that the drug candidates are more effective than morphine, non-addictive, and non-toxic at high doses. The UA has licensed the compounds to startup Regulonix. Continue reading
Author Archive: AZBio
Startup Licenses University of Arizona Technology That Shortens Cancer Cell Life
The University of Arizona has licensed a drug that aims to shorten the lives of cancer cells to startup Reglagene. The technology, invented at the UA College of Pharmacy and the UA BIO5 Institute by Laurence Hurley, PhD, and Vijay Gokhale, PhD, has been shown to be effective in shortening the lives of target cells, essentially inducing cancer cells to grow old and die.Continue reading
Young Entrepreneurs Receive FDA Clearance for Medical Device Poised to Disrupt Newborn Care Market
Through its empathy-driven innovation model, NeoLight develops technologies that treat infants with life threatening medical conditions.
TGen-USC study finds ‘Precision Medicine’ may not always be so precise
Team develops new tool, LumosVar, for discerning genetic variants; more genomic sequencing needed for clinical application to cancer patientsContinue reading
Heavy metal thunder: Protein can be switched on to conduct electricity like a metal
When pushing the boundaries of discovery, sometimes even the most experienced of scientists can get a surprise jolt from a completely unpredictable result.Continue reading
Biodesign researchers shrinks cost of device to diagnose tuberculosis in the field
With smartphones millions of times more powerful than the NASA Apollo computers that sent us to the moon in the 1960s, scientists have been eager to adapt them back here on Earth to better the planet.Continue reading
UA Startup Advances New Therapies for Vascular Dementia
Two patents have been awarded to the UA based on the novel approach of ProNeurogen to treating diseases causing memory loss and cognitive impairment.Continue reading
US FDA awards I-ACT for Children a grant for pediatric medicines & devices network
The US Food and Drug Administration has awarded the Institute for Advanced Clinical Trials for Children (I-ACT for Children) a grant to improve clinical trials of new drugs and devices for children. The award establishes an alliance among I-ACT for Children and PEDSnet, the James M. Anderson Center for Health Systems Excellence, Critical Path Institute and the National Capital Consortium for Pediatric Device Innovation, to work together with leading children’s institutions and health systems to address key gaps and challenges in pediatric clinical trials.Continue reading
UA Lab Seeks ‘Holy Grail of Gerontology’
What if you could experience full health until the very end of your life? UA researchers, led by Dr. Janko Nikolich-Zugich, think long-lasting immunity from disease might be possible — if the thymus and the T-cells it produces to fight infection can be brought back to work efficiently.Continue reading